Flatiron Health Announces Research to be Presented at American Society of Clinical Oncology 2022 Annual Meeting
Flatiron Health today announced three Flatiron-authored abstracts have been accepted for poster discussion and presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 3-7.
"As demonstrated by our research at ASCO this year, we are at the forefront of our industry to improve patient lives through the power of integrated evidence, and are committed to advance equitable care for all patients," said Carolyn Starrett, Flatiron CEO. "At Flatiron, we are reimagining the infrastructure of cancer care. We bring together science, technology, and medicine to transform possibilities into results and solve critical challenges with our partners."
Highlights include:
an investigation that uses one of the largest real-world datasets with a telemedicine variable available to assess patterns of use among patients with cancer during the COVID pandemic, illuminating health inequity
a study that uses integrated evidence to quantify the clinical value of multi-gene testing in early-stage lung adenocarcinoma, showcasing potential benefit in treatment decision-making
a study that evaluates and understands the value of ctDNA as a non-invasive tool to treat patients with advanced NSCLC by leveraging the Flatiron Health-Foundation Medicine Clinico-Genomic Database
About Flatiron
Flatiron Health is a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today and tomorrow. Through clinical and data science, we translate patient experiences into real-world evidence to improve treatment, inform policy, and advance research. Cancer is smart. Together, we can be smarter. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...
At the end of February 2024, the UK ran its second Hydrogen Week. During this week, Hyundai set two new records for the driving range of its fuel cell electric vehicles (FCEVs). While certainly a significant achievement, will the ultimate range of...
On April 16th, the Yiwu China Commodities City unveiled a new welcoming committee, comprising the region's top women entrepreneurs, to aid international buyers in sourcing local products. Over 120 skilled businesswomen from the committee will provide...
PitchBook, the premier data provider for the private and public equity markets today released The Global VC Ecosystem Dashboard that ranks the world's top startup cities. This dashboard leverages PitchBook data and PitchBook Institutional Research...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...